CARTESIAN THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.03 USD | +0.62% |
|
+17.42% | +1.68% |
Chart calendar Cartesian Therapeutics, Inc.
82d28eafcd075de.rvx1unhAzHXj2mQ1h_5PM08k5_jlWJfm__nd5oZ27L8.3o8-0BMsnViHsDJC_ZAlRz5d17qjIN-IoNS0stUVodPtzTveIjSnR7KfXA~1ddb1407c94e36734cea4df637eb31c6
Upcoming events on Cartesian Therapeutics, Inc.
Past events on Cartesian Therapeutics, Inc.
| 2024-04-09 03:00 pm | Needham Healthcare Conference |
| 2024-03-27 09:00 am | Extraordinary Shareholders Meeting |
| 2024-03-26 11:00 am | H.C. Wainwright Cell Therapy Virtual Conference |
| 2024-03-13 08:40 am | Leerink Partners Global Biopharma Conference |
| 2024-03-07 07:00 am | Q4 2023 Earnings Release |
| 2023-08-17 08:30 am | Q2 2023 Earnings Call |
| 2023-08-17 07:00 am | Q2 2023 Earnings Release |
| 2023-06-16 10:00 am | Annual General Meeting |
| 2023-05-30 | European Alliance of Associations for Rheumatology European Congress |
| 2023-05-04 08:30 am | Q1 2023 Earnings Call |
| 2023-05-04 07:30 am | Q1 2023 Earnings Release |
| 2023-03-21 08:30 am | DISSOLVE I & II SEL-212 Phase 3 Trail Results Call |
| 2023-03-02 08:30 am | Q4 2022 Earnings Call |
| 2023-03-01 | Q4 2022 Earnings Release |
| 2023-02-14 08:00 am | SVB Securities Global Biopharma Conference |
| 2022-11-14 01:35 pm | Immunology & Neurology Day |
| 2022-11-03 08:30 am | Q3 2022 Earnings Call |
| 2022-11-03 08:00 am | Q3 2022 Earnings Release |
| 2022-10-11 12:30 pm | European Society of Gene and Cell Therapy Conference - OR06 |
| 2022-09-30 02:30 pm | Jefferies Cell and Genetic Medicine Summit |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 26,0 10,6 145.32% | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -86,4 -14,3 -506.39% | -40,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,46 | -239 -13,7 -1645.21% | -32,2 |
|
Net income Million USD | Released Forecast Spread | -6,46 | -220 -13,7 -1506.3% | -37,8 |
|
EPS USD | Released Forecast Spread | 0,00 | -49,8 -0,60 -8200.01% | -1,62 |
| Announcement Date | 23/01/24 | 07/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,50 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -6,00 | -8,63 | -9,00 | -10,4 | -12,3 | -14,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,91 | -6,29 | -7,62 | -8,46 | -9,81 | -10,9 |
|
Net income Million USD | Released Forecast Spread | -5,91 | -8,14 | -8,31 | -9,73 | -11,7 | -13,5 |
|
EPS USD | Released Forecast Spread | -0,30 | -0,35 | -0,36 | -0,42 | -0,50 | -0,57 |
| Announcement Date | - | - | - | - | - | - |
More events
Past sector events for Cartesian Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RNAC Stock
- Calendar Cartesian Therapeutics, Inc.
